Vincerx Pharma Announces Cost-Cutting Measures and Exploration of Strategic Alternatives to Advance VIP943 Clinical Development

Quiver QuantitativeDec 4 06:50 ET

Express News | Vincerx Pharma Inc: To Streamline Operations and Focus Resources, Vincerx Will Implement a Significant Reduction in Force of Approximately 55%

ReutersDec 4 06:45 ET

Express News | Vincerx Pharma Inc: Will Begin Exploring Strategic Alternatives to Complement Ongoing Fundraising Efforts

ReutersDec 4 06:45 ET

Express News | Vincerx Pharma to Implement Cost-Controls to Support Advancing Phase 1 Study of Vip943

ReutersDec 4 06:45 ET

Vincerx Pharma to Implement Cost-Controls to Support Advancing Phase 1 Study of VIP943

GlobeNewswireDec 4 06:45 ET

Vincerx Pharma Inc: Strategic Advancements and Promising Pipeline Highlight Buy Rating

TipRanksNov 14 02:45 ET · Ratings